My Cart

Human CD200 R1 / CRTR2 Protein, His Tag, low endotoxin (MALS verified)

Customer Reviews
Cat. No. / Size
Price
Qty
CR2-H52H6-100ug
$360.00
CR2-H52H6-1mg
$2615.00
ETA of in-stock products:2 business days
Sub-Total$ 0

Product Details

  • Synonyms

    CD200R, CRTR2, MOX2R, OX2R

  • Source

    Human CD200 R1, His Tag (CR2-H52H6) is expressed from human 293 cells (HEK293). It contains AA Ala 27 - Leu 266 (Accession # AAQ19772.1).

    Predicted N-terminus: Ala 27

    Request for sequence
  • Molecular Characterization

    CD200 R1 Structure

    Other Tags and Version Biotin & Other Labeled Version

    This protein carries a polyhistidine tag at the C-terminus.

    The protein has a calculated MW of 28.7 kDa. The protein migrates as 48-65 kDa when calibrated against Star Ribbon Pre-stained Protein Marker under reducing (R) condition (SDS-PAGE) due to glycosylation.

  • Endotoxin

    Less than 0.01 EU per μg by the LAL method / rFC method.

  • Purity

    >90% as determined by SDS-PAGE.

    >95% as determined by SEC-MALS.

  • Formulation

    Lyophilized from 0.22 μm filtered solution in PBS, pH7.4 with trehalose as protectant.

    Contact us for customized product form or formulation.

  • Reconstitution

    Please see Certificate of Analysis for specific instructions.

    For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.

  • Storage

    For long term storage, the product should be stored at lyophilized state at -20°C or lower.

    Please avoid repeated freeze-thaw cycles.

    This product is stable after storage at:

    1. -20°C to -70°C for 12 months in lyophilized state;
    2. -70°C for 3 months under sterile conditions after reconstitution.
  • ACRO Quality Management System

    1. QMS(ISO, GMP)
    2. Quality Advantages
    3. Quality Control Process

Customers Also Viewed

Performance Data

  • SDS-PAGE

    CD200 R1 SDS-PAGE

    Human CD200 R1, His Tag on SDS-PAGE under reducing (R) condition. The gel was stained with Coomassie Blue. The purity of the protein is greater than 90% (With Star Ribbon Pre-stained Protein Marker).

  • SEC-MALS

    CD200 R1 SEC-MALS

    The purity of Human CD200 R1, His Tag (Cat. No. CR2-H52H6) is more than 95% and the molecular weight of this protein is around 40-55 kDa verified by SEC-MALS.

    Report
  • Bioactivity-ELISA

     CD200 R1 ELISA

    Immobilized Human CD200, Fc Tag (Cat. No. OX2-H5251) at 5 μg/mL (100 μL/well) can bind Human CD200 R1, His Tag (Cat. No. CR2-H52H6) with a linear range of 20-78 ng/mL (QC tested).

    Protocol

Customer Reviews
Writing Reviews

Background

Cell surface glycoprotein CD200 receptor 1 is a protein that in humans is encoded by the CD200R1 gene.
This gene encodes a receptor for the OX-2 membrane glycoprotein. Both the receptor and substrate are cell surface glycoproteins containing two immunoglobulin-like domains. This receptor is restricted to the surfaces of myeloid lineage cells and the receptor-substrate interaction may function as a myeloid downregulatory signal.
CD200 and its receptor CD200R are both type-1 membrane glycoproteins, which are members of the immunoglobulin superfamily (IgSF). Besides the inhibitory effect on macrophages, CD200/CD200R also play an important role in regulating the regulatory T cells, allergicreaction, autoimmune diseases, allograft, neurological diseases and other autoimmune-related diseases.
The interaction between CD200, which is mainly present in neurons but also in astrocytes, and CD200R1, which is mainly present in microglia, is one of the mechanisms involved in keeping the microglial proinflammatory phenotype under control in physiological conditions. Alterations in the expression of CD200 and CD200R1 have been described in neurodegenerative diseases, but little is known about the mechanism of regulation of these proteins under physiological or pathological conditions.

Recent Advances

 
Drug Development Progress
  • English Name:

    Cell surface glycoprotein CD200 receptor 1

  • Category:

  • Approved Drugs:

    0 Details

  • Drugs in Clinical Trials:

    3 Details

  • Highest Development Stage:

    Phase 2 Clinical

Drug Candidate Licensing
More
  • Basic Product Information
  • Product Details
  • Customers Also Viewed
  • Performance Data
  • Customer Reviews
  • Background